Shopping Cart 0
Cart Subtotal
USD 0

Synthon Holdings BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company's products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon Holdings BV-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Synthon Acquires LEX System From Biolex Therapeutics 11

Partnerships 13

Pfizer Enters into Agreement with Synthon 13

Antitope Enters into Agreement with Synthon Biopharma 14

MAB Discovery Enters into Research Agreement with Synthon for Antibodies 15

Licensing Agreements 16

Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16

MacroGenics Enters into Licensing Agreement with Synthon Biopharma 17

Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 18

Asset Transactions 19

Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 19

Synthon Holdings BV-Key Competitors 20

Synthon Holdings BV-Key Employees 21

Synthon Holdings BV-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Synthon Holdings BV, Pharmaceuticals & Healthcare, Key Facts 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synthon Acquires LEX System From Biolex Therapeutics 11

Pfizer Enters into Agreement with Synthon 13

Antitope Enters into Agreement with Synthon Biopharma 14

MAB Discovery Enters into Research Agreement with Synthon for Antibodies 15

Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16

MacroGenics Enters into Licensing Agreement with Synthon Biopharma 17

Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 18

Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 19

Synthon Holdings BV, Key Competitors 20

Synthon Holdings BV, Key Employees 21

Synthon Holdings BV, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company's products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon Holdings BV-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Synthon Acquires LEX System From Biolex Therapeutics 11

Partnerships 13

Pfizer Enters into Agreement with Synthon 13

Antitope Enters into Agreement with Synthon Biopharma 14

MAB Discovery Enters into Research Agreement with Synthon for Antibodies 15

Licensing Agreements 16

Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16

MacroGenics Enters into Licensing Agreement with Synthon Biopharma 17

Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 18

Asset Transactions 19

Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 19

Synthon Holdings BV-Key Competitors 20

Synthon Holdings BV-Key Employees 21

Synthon Holdings BV-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Synthon Holdings BV, Pharmaceuticals & Healthcare, Key Facts 2

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Synthon Holdings BV, Deals By Therapy Area, 2012 to YTD 2018 8

Synthon Holdings BV, Medical Devices Deals, 2012 to YTD 2018 9

Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synthon Acquires LEX System From Biolex Therapeutics 11

Pfizer Enters into Agreement with Synthon 13

Antitope Enters into Agreement with Synthon Biopharma 14

MAB Discovery Enters into Research Agreement with Synthon for Antibodies 15

Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16

MacroGenics Enters into Licensing Agreement with Synthon Biopharma 17

Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 18

Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 19

Synthon Holdings BV, Key Competitors 20

Synthon Holdings BV, Key Employees 21

Synthon Holdings BV, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS